Literature DB >> 28537761

Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy.

Dario Di Perri1,2, John A Lee1, Anne Bol1, François-Xavier Hanin1,3, Guillaume Janssens4, Daniel Labar1, Annie Robert5, Edmond Sterpin1, Xavier Geets1,2.   

Abstract

BACKGROUND: PET-guided dose painting (DP) aims to target radioresistant tumour regions in order to improve radiotherapy (RT) outcome. Besides the well-known [18F]fluorodeoxyglucose (FDG), the hypoxia positron emission tomography (PET) tracer [18F]fluoroazomycin arabinoside (FAZA) could provide further useful information to guide the radiation dose prescription. In this study, we compare the spatial distributions of FDG and FAZA PET uptakes in lung tumours.
MATERIAL AND METHODS: Fourteen patients with unresectable lung cancer underwent FDG and FAZA 4D-PET/CT on consecutive days at three time-points: prior to RT (pre), and during the second (w2), and the third (w3) weeks of RT. All PET/CT were reconstructed in their time-averaged midposition (MidP). The metabolic tumour volume (MTV: FDG standardised uptake value (SUV) > 50% SUVmax), and the hypoxic volume (HV: FAZA SUV > 1.4) were delineated within the gross tumour volume (GTVCT). FDG and FAZA intratumoral PET uptake distributions were subsequently pairwise compared, using both volume-, and voxel-based analyses.
RESULTS: Volume-based analysis showed large overlap between MTV and HV: median overlapping fraction was 0.90, 0.94 and 0.94, at the pre, w2 and w3 time-points, respectively. Voxel-wise analysis between FDG and FAZA intratumoral PET uptake distributions showed high correlation: median Spearman's rank correlation coefficient was 0.76, 0.77 and 0.76, at the pre, w2 and w3 time-points, respectively. Interestingly, tumours with high FAZA uptake tended to show more similarity between FDG and FAZA intratumoral uptake distributions than those with low FAZA uptake.
CONCLUSIONS: In unresectable lung carcinomas, FDG and FAZA PET uptake distributions displayed unexpectedly strong similarity, despite the distinct pathways targeted by these tracers. Hypoxia PET with FAZA brought very little added value over FDG from the perspective of DP in this population.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28537761     DOI: 10.1080/0284186X.2017.1329594

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

Review 1.  Oxygen Sensing, Hypoxia Tracing and in Vivo Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases.

Authors:  Vincenzo Mirabello; Fernando Cortezon-Tamarit; Sofia I Pascu
Journal:  Front Chem       Date:  2018-02-23       Impact factor: 5.221

Review 2.  Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.

Authors:  Evelien A J van Genugten; Jetty A M Weijers; Sandra Heskamp; Manfred Kneilling; Michel M van den Heuvel; Berber Piet; Johan Bussink; Lizza E L Hendriks; Erik H J G Aarntzen
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

3.  Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using 18F-FDG PET/CT Imaging Feedback.

Authors:  Shupeng Chen; An Qin; Di Yan
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

4.  Alternative and New Radiopharmaceutical Agents for Lung Cancer.

Authors:  Silvi Telo; Letizia Calderoni; Sara Vichi; Federico Zagni; Paolo Castellucci; Stefano Fanti
Journal:  Curr Radiopharm       Date:  2020

5.  4D-CT Attenuation Correction in Respiratory-Gated PET for Hypoxia Imaging: Is It Really Beneficial?

Authors:  Brandon Driscoll; Douglass Vines; Tina Shek; Julia Publicover; Ivan Yeung; Stephen Breen; David Jaffray
Journal:  Tomography       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.